As we wait for the first human trial results of NR due out soon, the latest news is that Procter & Gamble recently entered an exclusive deal with NR wholesaler ChromaDex:
Global News Wire, Nov 05:
“Under the terms of the agreement, ChromaDex will provide P&G exclusivity to its new proprietary ingredient for use in P&G branded products. P&G will make an undisclosed up-front payment to ChromaDex as well as other payments based on achievement of various milestones. ”
Well, that should significantly expand the NR user base next year. So how will the deal affect the cost to the consumer?